LoQus23 Therapeutics Ltd.

LoQus23 is a DDF-formed company developing small molecules to treat Huntington’s disease and other triplet repeat diseases via targeting the disease-driving aberrant DNA mismatch repair system.

All Portfolio Companies
Location
UK/EU
Fund
DDF-1